Tetra Bio-Pharma Discusses The Potential of Their ARDS-003 Drug in The Fight Against COVID-19 with The Stock Day Podcast

The Stock Day Podcast welcomed Tetra Bio-Pharma (TSXV:TBP)(OTCQB:TBPMF)(“the Company”), a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Chief Regulatoy Officer and CEO of the Company, Dr. Guy Chamberland, joined Stock Day host Everett Jolly.  READ FULL PRESS RELEASE: https://stockdaymedia.com/tetra-bio-pharma-discusses-the-potential-of-their-ards-003-drug-in-the-fight-against-covid-19-with-the-stock-day-podcast-tbpmf-june-22-2020/ Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy